Ping for your interest
FLCCC Response: While open-label studies can lead to bias when measuring “subjective” endpoints, most trials used multiple objective endpoints, including viral load, viral clearance, and death. A dozen studies and meta-analyses reported statistically significant benefits across objective endpoints.
My response - it it is showing positive, real and across the board results and is saving lives and improving outcomes in the middle of what is purported to be a deadly epidemic - I really don't care if the test is not double blind and the placebo effect may entering into the equation. In fact, if it is, so much the better
We are weighing lives of real people here , not statistics.
Our gov health bureaucracy is seriously f’ed up on their priorities.
The restrictions and the Cavuto shrieked warnings that these treatments will kill everyone that tries them are no longer needed to hurt Trump, and
they already manufactured the deaths they needed to keep the lockdowns
and travel restrictions, and NY Vaccination passports...
This was January 6th.
Any response from CDC?